Total intravenous anesthesia for geriatric hip fracture with severe systemic disease

Purpose Our study aimed to determine the impact of a novel technique of anesthesia administration on the clinical outcomes and complications in geriatric patients with severe systemic disease undergoing hip surgery. Methods We retrospectively identified patients aged > 65 years with severe system...

Full description

Saved in:
Bibliographic Details
Published in:European journal of trauma and emergency surgery (Munich : 2007) 2023-10, Vol.49 (5), p.2139-2145
Main Authors: Huang, Yu-Yi, Hui, Chung-Kun, Lau, Ngi-Chiong, Ng, Yuet-Tong, Lin, Tung-Yi, Chen, Chien-Hao, Wang, Ying-Chih, Tang, Hao-Che, Chen, Dave Wei-Chih, Chang, Chia-Wei
Format: Article
Language:English
Subjects:
Anesthesia
Critical Care Medicine
Emergency Medicine
Fractures
Geriatrics
Hip joint
Intensive
Medicine
Medicine & Public Health
Mortality
Original
Original Article
Sports Medicine
Surgery
Surgical Orthopedics
Systemic diseases
Traumatic Surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Our study aimed to determine the impact of a novel technique of anesthesia administration on the clinical outcomes and complications in geriatric patients with severe systemic disease undergoing hip surgery. Methods We retrospectively identified patients aged > 65 years with severe systemic disease that was a constant of life [American Society of Anesthesiologists (ASA) IV] who underwent surgery for hip fracture between January 2018 and January 2020. The patients were divided into two groups: Group I [fascia iliaca compartment block plus propofol-based total intravenous anesthesia (FICB + TIVA)] and Group II [general anesthesia (GA)]. The primary outcomes were 30-day and 1-year mortality. The secondary outcomes included length of hospital stay, length of intensive care unit (ICU) stay, postoperative morbidity, Visual Analog Scale score, and consumption of analgesics. Results There was no significant difference in the 30-day mortality (5 vs. 3.8%, p  = 0.85) and 1-year mortality (15 vs. 12%, p  = 0.73) between the groups. Group I had significantly lower ICU requirements ( p  = 0.01) and shorter lengths of ICU stay ( p  
ISSN:1863-9933
1863-9941
DOI:10.1007/s00068-023-02291-z